(a) Every individual or group hospital or medical services plan contract delivered
or renewed in this state shall include coverage of the cost for human leukocyte antigen
testing, also referred to as histocompatibility locus antigen testing, for A, B, and
DR antigens for utilization in bone marrow transplantation. The testing must be performed in a facility that is accredited by the American Association
of Blood Banks or its successors, and is licensed under the Clinical Laboratory Improvement
Act, 42 U.S.C. § 263a, as it may be from time to time amended. At the time of the testing, the person being tested must complete and sign an informed
consent form that also authorizes the results of the test to be used for participation
in the National Marrow Donor Program. The group hospital or medical services plan contract may limit each subscriber to
one of these testings per lifetime.
(b) This section shall not apply to insurance coverage providing benefits for: (1)
hospital confinement indemnity; (2) disability income; (3) accident only; (4) long
term care; (5) Medicare supplement; (6) limited benefit health; (7) specified disease
indemnity; (8) sickness or bodily injury or death by accident or both; and (9) other
limited benefit policies.
FindLaw Codes may not reflect the most recent version of the law in your jurisdiction. Please verify the status of the code you are researching with the state legislature or via Westlaw before relying on it for your legal needs.
Was this helpful?
Welcome to FindLaw's Cases & Codes
A free source of state and federal court opinions, state laws, and the United States Code. For more information about the legal concepts addressed by these cases and statutes, visit FindLaw's Learn About the Law.